SEARCH

SEARCH BY CITATION

References

  • Altman PL, Dittmer DS. (1974) Biological data book, 2nd ed., Vol. 3. Federation of American Societies for Experimental Biology, Bethesda, MD, pp. 17021710.
  • Ben-Ari Y, Tremblay E, Ottersen OP. (1980) Injections of kainic acid into the amygdaloid complex of the rat: an electrographic, clinical and histological study in relation to the pathology of epilepsy. Neuroscience 5:515528.
  • Bersudsky Y, Applebaum J, Gaiduk Y, Sharony L, Mishory A, Podberezsky A, Agam G, Belmaker RH. (2010) Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial. Bipolar Disord 12:376382.
  • Bialer M, White HS. (2010) Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov 9:6882.
  • Bialer M, Twyman RE, White HS. (2004) Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels. Epilepsy Behav 5:866872.
  • Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. (2010) Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X). Epilepsy Res 92:89124.
  • Blotnik S, Bergman F, Bialer M. (1996) Valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats. Drug Metab Disposit 24:560564.
  • Bolanos AR, Sarkisian M, Yang Y, Hori A, Helmers SL, Mikati M, Tandon P, Stafstrom CE, Holmes GL. (1998) Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 51:4148.
  • Brandt C, Gastens AM, Sun M, Hausknecht M, Löscher W. (2006) Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 51:789804.
  • Carpentier P, Delamanche IS, Le Bert M, Blanchet G, Bouchaud C. (1990) Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology 11:493508.
  • Cha BH, Silveira DC, Liu X, Hu Y, Holmes GL. (2002) Effect of topiramate following recurrent and prolonged seizures during early development. Epilepsy Res 51:217232.
  • Cunha AO, Mortari MR, Liberato JL, dos Santos WF. (2009) Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus. Basic Clin Pharmacol Toxicol 104:470477.
  • DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D. (1996) A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46:10291035.
  • Dichter MA. (2009) Emerging concepts in the pathogenesis of epilepsy and epileptogenesis. Arch Neurol 66:443447.
  • François J, Koning E, Ferrandon A, Nehlig A. (2006) The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 72:147163.
  • Frisch C, Kudin AP, Elger CE, Kunz WS, Helmstaedter C. (2007) Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent. Epilepsy Res 73:173180.
  • Goodkin H, Riviello J Jr. (2011) Status epilepticus. In Wyllie E (Ed.) Wyllie’s treatment of epilepsy: principles and practice. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 469485.
  • Hamed SA. (2009) The aspects and mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medications. CNS Neurosci Ther 15:134156.
  • Hauser WA, Rich SS, Annegers JF, Anderson VE. (1990) Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology 40:11631170.
  • Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. (1998) Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology 50:735741.
  • Jones DM, Esmaeil N, Maren S, Macdonald RL. (2002) Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res 50:301312.
  • Kaufmann D, Bialer M, Shimshoni JA, Devor M, Yagen B. (2009) Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues. J Med Chem 52:72367248.
  • Klitgaard H. (2001) Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 42(Suppl. 4):1318.
  • Kristensen BW, Noraberg J, Zimmer J. (2001) Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Brain Res 917:2144.
  • Krumholz A. (1999) Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Neurophysiol 16:314322; discussion 353.
  • Lallement G, Pernot-Marino I, Baubichon D, Burckhart MF, Carpentier P, Blanchet G. (1994) Modulation of soman-induced neuropathology with an anticonvulsant regimen. Neuroreport 5:22652268.
  • Lee MG, Chou JY, Lee KH, Choi BJ, Kim SK, Kim CY. (1997) MK-801 augments pilocarpine-induced electrographic seizure but protects against brain damage in rats. Prog Neuropsychopharmacol Biol Psychiatry 21:331344.
  • Löscher W, Brandt C. (2010) Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 62:668700.
  • Mazarati AM, Baldwin R, Klitgaard H, Matagne A, Wasterlain CG. (2004) Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Res 58:167174.
  • McDonough JH, Shih TM. (1993) Pharmacological modulation of soman-induced seizures. Neurosci Biobehav Rev 17:203215.
  • McDonough JH, Dochterman LW, Smith CD, Shih TM. (1995) Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 16:123132.
  • McDonough JH, Zoeffel LD, McMonagle J, Copeland TL, Smith CD, Shih TM. (2000) Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 38:114.
  • Meador KJ. (2002) Cognitive outcomes and predictive factors in epilepsy. Neurology 58:S21S26.
  • Mello LE, Cavalheiro EA, Tan AM, Kupfer WR, Pretorius JK, Babb TL, Finch DM. (1993) Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34:985995.
  • Noraberg J. (2004) Organotypic brain slice cultures: an efficient and reliable method for neurotoxicological screening and mechanistic studies. Altern Lab Anim 32:329337.
  • Pessah N, Bialer M, Wlodarczyk B, Finnell RH, Yagen B. (2009) Alpha-fluoro-2,2,3,3-tetramethylcyclopropanecarboxamide, a novel potent anticonvulsant derivative of a cyclic analogue of valproic acid. J Med Chem 52:22332242.
  • Pitkänen A, Nissinen J, Nairismägi J, Lukasiuk K, Gröhn OH, Miettinen R, Kauppinen R. (2002) Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog Brain Res 135:6783.
  • Pitkänen A, Kharatishvili I, Narkilahti S, Lukasiuk K, Nissinen J. (2005) Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. Epilepsy Res 63:2742.
  • Racine R. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizures. Electroencephalogr Clin Neurophysiol 3:281294.
  • Rogawski MA. (2006) Molecular targets versus models for new antiepileptic drug discovery. Epilepsy Res 68:2228.
  • Shih TM, McDonough JH, Koplovitz I. (1999) Anticonvulsants for soman-induced seizure activity. J Biomed Sci, 6:8696.
  • Temkin NR, Dikmen SS, Anderson GD, Wilensky AJ, Holmes MD, Cohen W, Newell DW, Nelson P, Awan A, Winn HR. (1999) Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 91:593600.
  • Umka J, Mustafa S, El Beltagy M, Thorpe A, Latif L, Bennett G, Wigmore PM. (2010) Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 166:1522.
  • Zheng Y, Moussally J, Cash SS, Karnam HB, Cole AJ. (2010) Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies. Neuropharmacology 58:793798.